About this trial
Periodontitis is a chronic, multifactorial inflammatory disease primarily caused by dysbiotic plaque biofilms, characterized by the progressive destruction of the supporting structures of the teeth. In advanced stages (Stage III/IV), periodontitis leads to significant attachment and bone loss, often culminating in tooth loss and a negative impact on the patient's quality of life. Recent evidence has emphasized the systemic implications of periodontal inflammation, suggesting a bidirectional relationship between periodontitis and various systemic conditions, especially cardiovascular diseases
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 30-60 years.
Systemically healthy (based on medical history and physician clearance, if needed).
No history of periodontal treatment within the last 6 months.
Disqualifiers
1. History of systemic diseases affecting periodontium (e.g., uncontrolled diabetes, autoimmune diseases, osteoporosis).
Trial population
cross sectional study in upper egypt to detect the level of LDL in advanced periodontitis patient
Trial design
Other
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
The concentration of oxLDL in GCF
The concentration of oxLDL in GCF, measured in pg/mL, in geriatric patients with Stage III/IV periodontitis compared to periodontally healthy geriatric individuals.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
shaimaa hamdy
Lead sponsor
Minia University
Sponsor institution
This trial is not recruiting at the moment. You can still explore other options: